Synthesis of Platelet Activating Factor by Ocular Tissue From Inflamed Eyes
- 1 March 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 109 (3) , 410-3
- https://doi.org/10.1001/archopht.1991.01080030112049
Abstract
Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 mumol/L), and supernatants were extracted with chloroform-methanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.Keywords
This publication has 9 references indexed in Scilit:
- Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxinCellular Immunology, 1990
- Prostaglandin-Independent Inhibition of Ocular Vascular Permeability by a Platelet-Activating Factor AntagonistArchives of Ophthalmology (1950), 1988
- A platelet-activating factor antagonist inhibits interleukin 1-induced inflammationBiochemical and Biophysical Research Communications, 1988
- The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase productsBiochemical and Biophysical Research Communications, 1987
- Platelet‐activating factor: an endogenous mediator for bowel necrosis in endotoxemiaThe FASEB Journal, 1987
- Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.Journal of Clinical Investigation, 1987
- EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 1986
- Involvement of leukotrienes and PAF-acether in the increased microvascular permeability of the rabbit retinaInflammation Research, 1984
- Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophilsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980